Inovio Pharmaceuticals
INO
#8887
Rank
โ‚ฌ0.12 B
Marketcap
1,81ย โ‚ฌ
Share price
-1.84%
Change (1 day)
-52.60%
Change (1 year)

P/S ratio for Inovio Pharmaceuticals (INO)

P/S ratio as of December 2025 (TTM): 803

According to Inovio Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -19.0. At the end of 2025 the company had a P/S ratio of 723.

P/S ratio history for Inovio Pharmaceuticals from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
2025723133.15%
202431085.27%
2023167341.21%
202237.9-93.59%
2021592192.41%
2020202148.69%
201981.3537.59%
201812.844.44%
20178.83-39.22%
201614.521.49%
201512.0-77.57%
201453.317.75%
201345.3158.75%
201217.5214.73%
20115.56-71.71%
201019.753.06%
200912.817.71%
200810.930.14%
20078.38-75.2%
200633.8176.32%
200512.2-80.32%
200462.2-93.71%
20039881227.56%
200274.52126.05%
20013.34

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.34-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.49-99.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
17.1-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4.51-99.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
3.85-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
2.34-99.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
5.26-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA